Keros Therapeutics (KROS) EPS (Basic) (2019 - 2026)
Keros Therapeutics' (KROS) quarterly EPS (Basic) came in at -$0.63 in Q4 2025, up 48.73% YoY from -$0.42 in Q4 2024, and down 251.72% on a QoQ basis from -$0.18 in Q3 2025.
Keros Therapeutics (KROS) EPS (Basic) (2019 - 2026) Analysis & Trends
Keros Therapeutics (KROS) has 7 years of EPS (Basic) data on file, last reported at -$0.63 in Q4 2025.
- Quarterly EPS (Basic) rose 48.73% year-over-year to -$0.63 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.34 (up 146.71% YoY) and the FY2025 annual result came in at $2.34, up 146.71% from the prior year.
- EPS (Basic) slipped to -$0.63 in Q4 2025, from -$0.18 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $3.66 in Q1 2025 to a low of -$1.41 in Q3 2024.
- A 5-year average of -$0.75 and a median of -$1.07 in 2022 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) sank 295.86% — and 2025, when it soared 402.95%.
- Tracing KROS's EPS (Basic) over 5 years: stood at -$0.3 in 2021, then slumped by 295.86% to -$1.18 in 2022, then fell by 16.07% to -$1.37 in 2023, then climbed by 10.04% to -$1.23 in 2024, then jumped by 48.73% to -$0.63 in 2025.
- The last three EPS (Basic) figures came in at -$0.63 (Q4 2025), -$0.18 (Q3 2025), and -$0.76 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.23 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.18 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | Keros Therapeutics | 217.21 Mn | -40.40 Mn | - | -1.45 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.45 |
| Dec 31, 2025 | -0.63 |
| Sep 30, 2025 | -0.18 |
| Jun 30, 2025 | -0.76 |
| Mar 31, 2025 | 3.66 |
| Dec 31, 2024 | -1.23 |
| Sep 30, 2024 | -1.41 |
| Jun 30, 2024 | -1.25 |
| Mar 31, 2024 | -1.21 |
| Dec 31, 2023 | -1.37 |
| Sep 30, 2023 | -1.33 |
| Jun 30, 2023 | -1.27 |
| Mar 31, 2023 | -1.26 |
| Dec 31, 2022 | -1.18 |
| Sep 30, 2022 | -0.92 |
| Jun 30, 2022 | -1.13 |
| Mar 31, 2022 | -1.01 |
| Dec 31, 2021 | -0.30 |
| Sep 30, 2021 | -0.87 |
| Jun 30, 2021 | -0.67 |